SS
PASG icon

SBI Securities’s Passage Bio PASG Stock Holding History

SBI Securities’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$973 Sell
124
-18
-13% -$186 ﹤0.01% 2665
2025
Q4 		$1.68K Hold
142
– – ﹤0.01% 2455
2025
Q3 		$1.14K Sell
142
-3
-2% -$21 ﹤0.01% 2641
2025
Q2 		$1.16K Sell
145
-119
-45% -$869 ﹤0.01% 2620
2025
Q1 		$1.86K Buy
264
+146
+124% +$1.58K ﹤0.01% 2320
2024
Q4 		$1.34K Buy
+118
New +$1.54K ﹤0.01% 2478

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SBI Securities's PASG Position: Q1 2026 in Review

SBI Securities reduced its Passage Bio (PASG) stake by 13% in Q1 2026, selling an estimated $186 and leaving 124 shares worth $973. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

SBI Securities first reported a position in PASG in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.86K in Q1 2025. 35 funds tracked by Wall St. Rank hold PASG as of Q1 2026.

  • SBI Securities held 124 shares of Passage Bio worth $973 as of Q1 2026.
  • SBI Securities sold 18 Passage Bio shares in Q1 2026, an estimated $186.
  • Passage Bio made up ﹤0.01% of SBI Securities's portfolio in Q1 2026, its #2665 holding.
  • SBI Securities first reported a position in Passage Bio in Q4 2024 and has held it in 6 quarters since.
  • SBI Securities's Passage Bio position peaked at $1.86K in Q1 2025.
  • 35 funds tracked by Wall St. Rank held Passage Bio as of Q1 2026.

Based on SBI Securities's 13F filing for Q1 2026, filed 28 Apr 2026.